Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

VUV Analytics introduces HYDRA™: A breakthrough Vacuum Ultraviolet Detector for Liquid Chromatography Novadip appoints Soumya Chandramouli as Chief Financial Officer San José City Council unanimously approves next phase of San José Airport Connector Project NorthSea Therapeutics announces publication of positive results from Phase 2b ICONA clinical trial of icosabutate in biopsy-confirmed F1-F3 MASH in Journal of Hepatology Ventyx Biosciences announces presentation of data from the Phase 2 trial of allosteric TYK2 inhibitor VTX958 in Crohn’s Disease at ECCO 2025 Ventyx Biosciences highlights 2025 pipeline strategy and provides clinical updates on its NLRP3 inhibitor portfolio
Back To News
INTERlink AI
October 17, 2017

INTERlink AI

Provider of an automated solution for pharmacy pill-dispensing.

Cookie Policy Website powered by 100% renewable energy Privacy Policy